CollPlant Biotechnologies (CLGN) Shares Outstanding (2017 - 2025)
CollPlant Biotechnologies (CLGN) reported Shares Outstanding of $12.8 million for Q4 2025, up 11.77% on a YoY basis from $11.5 million in Q4 2024, and up 11.77% quarter-over-quarter from $11.5 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Shares Outstanding (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Shares Outstanding for 9 years, with the latest figure at $12.8 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding rose 11.77% year-over-year to $12.8 million; the trailing twelve-month figure through Dec 2025 stood at $12.8 million (up 11.77% YoY), and the FY2025 full-year result was $12.8 million, up 11.77% from the prior year.
- Shares Outstanding for Q4 2025 stood at $12.8 million, up from $11.5 million in the prior quarter.
- The five-year high for Shares Outstanding was $12.8 million in Q4 2025, with the low at $10.7 million in Q4 2021.
- Historically, Shares Outstanding has averaged $11.5 million across 5 years, with a median of $11.5 million in 2023.
- Annual changes were most pronounced in 2021 — Shares Outstanding jumped 53.97% — and 2024, when it rose 0.02%.
- CollPlant Biotechnologies' Shares Outstanding stood at $10.7 million in 2021, then gained by 4.33% to $11.2 million in 2022, then advanced by 2.38% to $11.5 million in 2023, then advanced by 0.02% to $11.5 million in 2024, then climbed by 11.77% to $12.8 million in 2025.
- The last three Shares Outstanding figures came in at $12.8 million (Q4 2025), $11.5 million (Q4 2024), and $11.5 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 91.57 Bn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.80 Mn |
| Dec 31, 2025 | 12.80 Mn |
| Dec 31, 2025 | 12.80 Mn |
| Dec 31, 2025 | 12.80 Mn |
| Dec 31, 2025 | 12.80 Mn |
| Dec 31, 2025 | 12.80 Mn |
| Dec 31, 2025 | 12.80 Mn |
| Dec 31, 2025 | 12.80 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Dec 31, 2024 | 11.45 Mn |
| Dec 31, 2023 | 11.45 Mn |
| Dec 31, 2023 | 11.45 Mn |
| Dec 31, 2023 | 11.45 Mn |
| Dec 31, 2023 | 11.45 Mn |